Omlonti

Active Ingredient(s): Omidenepag Isopropyl
FDA Approved: * September 22, 2022
Pharm Company: * SANTEN
Category: Vision / Eye Health
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Omlonti .02 mg/ml Ophthalmic Solution/ Drops
NDC: 65086-002
Labeler:
Santen Incorporated